Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040456/0/en/Xilio-Therapeutics-Announces-Pipeline-and-Business-Updates-and-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
24 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/24/3031557/0/en/Xilio-Therapeutics-to-Present-at-TD-Cowen-45th-Annual-Health-Care-Conference.html
13 Feb 2025
// PRESS RELEASE
https://news.abbvie.com/2025-02-12-AbbVie-and-Xilio-Therapeutics-Announce-Collaboration-and-Option-Agreement-to-Develop-Novel-Tumor-Activated-Immunotherapies
03 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/03/3019882/0/en/Xilio-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
21 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/21/3013106/0/en/Xilio-Therapeutics-Announces-Initial-Phase-2-Data-for-Vilastobart-XTX101-a-Tumor-Activated-Anti-CTLA-4-in-Combination-with-Atezolizumab-in-Patients-with-Metastatic-Microsatellite-S.html
17 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/17/3011716/0/en/Xilio-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE